Please assess the completion status of the following clinical trial:

Trial Title: An Advanced Echocardiographic Evaluation of Nebivolol

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Diagnosis of hypertension~2. Written informed consent before initiation of any study related procedure~3. Baseline Blood pressure \> 140 systolic or \>90 diastolic if on no antihypertensive therapy.~4. Currently taking one antihypertensive or one antihypertensive and one diuretic for the treatment of hypertension.~Exclusion Criteria:~1. Physical limitations resulting in a limited ability to walk on treadmill for stress echo~2. Intolerance to beta blockers~3. On more than one medication for the treatment of hypertension unless the second medication is a diuretic.~4. Currently pregnant or breast feeding.~5. LFT \> 3 X ULN~6. HgA1C \> 7~7. Participation in other clinical research studies involving the evaluation of other investigational drugs or devices within past 30 days of enrollment~8. Unwilling to follow protocol or return for study related procedures.~9. Any of the following conditions:~   Coronary artery disease Heart failure Valvular heart disease Ischemic heart disease Atrial fibrillation Pacemaker ICD Hyperlipidemia Diabetes Mellitus Stroke/TIA Anemia COPD Asthma Renal failure requiring dialysis Liver failure Cirrhosis Thyroid dysfunction~10. Any other medical condition that in the PI's opinion could affect myocardial function.~11. Current ETOH or illicit drug abuse -

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Nebivolol 5 or 10 mg, oral, daily (Type: EXPERIMENTAL): Subject will receive either 5 or 10 mg of oral nebivolol daily. Dose will be determined by control of blood pressure.

Based on this trial design, predict the completion outcome and termination type (if applicable).